IM Cannabis (IMCC) Interest & Investment Income (2020 - 2025)
IM Cannabis' (IMCC) quarterly Interest & Investment Income came in at $179271.6 in Q4 2025, down 85.41% year-on-year from $1.2 million in Q4 2024, and down 77.79% quarter-over-quarter from $807291.5 in Q3 2025.
IM Cannabis (IMCC) Interest & Investment Income (2020 - 2025) Analysis & Trends
IM Cannabis' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $179271.6 for Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 85.41% year-over-year to $179271.6 in Q4 2025; TTM through Dec 2025 was $3.6 million, a 187.39% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 52.35% from the prior year.
- Interest & Investment Income slipped to $179271.6 in Q4 2025 per IMCC's latest filing, from $807291.5 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $6.8 million in Q3 2021 and bottomed at -$10389.6 in Q1 2024.
- The 5-year median for Interest & Investment Income is $1.3 million (2025), against an average of $2.1 million.
- Across the five-year window, Interest & Investment Income slumped 100.4% in 2024 and soared 110027.24% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $1.1 million in 2021, then jumped by 101.37% to $2.2 million in 2022, then jumped by 109.48% to $4.5 million in 2023, then plunged by 72.75% to $1.2 million in 2024, then slumped by 85.41% to $179271.6 in 2025.
- Per Business Quant, the three latest IMCC Interest & Investment Income figures stand at $179271.6 (Q4 2025), $807291.5 (Q3 2025), and $1.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 554,496.00 | -177,626.51 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 179,271.57 |
| Sep 30, 2025 | 807,291.49 |
| Jun 30, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 733.05 |
| Jun 30, 2024 | 25,589.92 |
| Mar 31, 2024 | -10,389.58 |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 184,990.76 |
| Mar 31, 2023 | 2.61 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 918,562.00 |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 6.85 Mn |
| Jun 30, 2021 | 5.05 Mn |
| Mar 31, 2021 | 5.71 Mn |
| Dec 31, 2020 | -115,058.20 |
| Sep 30, 2020 | 890,002.47 |